Intermittent Dosing With Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model

Cancer Prevention Research - United States
doi 10.1158/1940-6207.capr-17-0038
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2012English

Chemoprevention of Azoxymethane-Induced Colon Carcinogenesis by Delta-Tocotrienol

Cancer Prevention Research
MedicineCancer ResearchOncology
2019English

Aspirin as a Chemoprevention Agent for Colorectal Cancer

Current Drug Metabolism
Clinical BiochemistryPharmacology
2012English

Intermittent Dosing of Cinacalcet Is Also Effective in Treating Secondary Hyperparathyroidism in Hemodialysis Patients

Pharmaceutica Analytica Acta
2013English

18f-FLT PET/CT Imaging in Patients With Advanced Solid Malignancies Treated With Axitinib on an Intermittent Dosing Regimen

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2016English

PTEN Status in Advanced Colorectal Cancer Treated With Cetuximab

British Journal of Cancer
Cancer ResearchOncology
2009English

Retain Intermittent Dosing of Carbapenems.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

An in Vivo Mouse Model of Pelvic Recurrence of Human Colorectal Cancer

Scientific Reports
Multidisciplinary
2019English

Clinical and Experimental Studies on Chemoprevention of Colorectal Cancer Using Piroxycam.

Nippon Daicho Komonbyo Gakkai Zasshi
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy